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The process for fabrication of a microarray from geno-
mic DNA for whole proteome microarrays for B. pseu-
domallei may have application for Mycobacterium
tuberculosis (M.tb). In the process, PCR is done on the
DNA to amplify the open reading frames, genes are
cloned by in vivo recombination, and mini-preps are
made, isolating the plasmids produced by the recombi-
nation process. Then, in vitro transcription and transla-
tion reactions occur. Lastly, the reactions are brought to
a microarray printer and the microarray chips are
printed, using nitrocellulose-coated slides and without
doing protein purification. The heart of the process is
the high throughput cloning approach our team devel-
oped. Twenty nucleotide extensions are added to the
PCR products so that the genes, although all different,
have the same N-terminal and C-terminal sequences.
The gene-specific primers are homologous with 33
nucleotide vector-specific ‘adapter’ sequences. The plas-
mids are transformed into chemically competent E. coli
and grown overnight. The protein produced in the in
vitro transcription and translation reactions, driven by a
T-7 promoter, has both a HIS tag and a HA tag. The
efficiency rate for producing clones by this method is
greater than 95 percent, based on an analysis of 4,109
gene targets that produced 3,998 cloned genes. To test
protein expression efficiency, we probed two arrays with
monoclonal antibodies and then a secondary antibody.
Out of 11 print runs, 2,265 chips produced 4,530 arrays,
or a greater than 90 percent protein expression effi-
ciency rate. Finally we tested batch-to-batch reproduci-
bility by taking two batches of chips and track the signal
of the HIS tag.
In a case-control M.tb study, our lab examined smear
positive culture test results in individuals from endemic
countries and from healthy individuals in non-endemic
countries. In a series of projects involving 25 infectious
disease agents, our lab has produced 18,000 proteins,
printed 17,000 arrays, and probed 8,000 sera. The goal
of this research, is to develop multi-variant microarray
chips that contain several antigens, so that only one
blood sample is required from an individual to deter-
mine a diagnosis.
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